1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Urinary System Drugs Market Size by Type: 2016 VS 2021 VS 2027 1.2.2 Injection 1.2.3 Tablets 1.2.4 Capsule 1.2.5 Suppository 1.2.6 Granules 1.2.7 Powder 1.2.8 Pills 1.2.9 Cream 1.2.10 Others 1.3 Market by Application 1.3.1 Global Urinary System Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Kidney Disease Medication 1.3.3 Medication For Prostate Disease 1.3.4 Male Dysfunction 1.3.5 Lithotripsy Drug 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Urinary System Drugs Market Perspective (2016-2027) 2.2 Global Urinary System Drugs Growth Trends by Regions 2.2.1 Urinary System Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Urinary System Drugs Historic Market Size by Regions (2016-2021) 2.2.3 Urinary System Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy 2.3.1 Urinary System Drugs Industry Trends 2.3.2 Urinary System Drugs Market Drivers 2.3.3 Urinary System Drugs Market Challenges 2.3.4 Urinary System Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Urinary System Drugs Players by Market Size 3.1.1 Players Covered: Ranking by Urinary System Drugs Revenue 3.1.2 Global Top Urinary System Drugs Players by Revenue (2016-2021) 3.1.3 Global Urinary System Drugs Revenue Market Share by Players (2016-2021) 3.1.4 Global Urinary System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Urinary System Drugs Market Concentration Ratio 3.2.1 Global Urinary System Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 5 and Top 10 Players by Urinary System Drugs Revenue in 2020 3.3 Urinary System Drugs Key Players Head office and Area Served 3.4 Key Players Urinary System Drugs Product Solution and Service 3.5 Date of Enter into Urinary System Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Urinary System Drugs Breakdown Data by Type (2016-2027) 4.1 Global Urinary System Drugs Historic Market Size by Type (2016-2021) 4.2 Global Urinary System Drugs Forecasted Market Size by Type (2022-2027) 5 Global Urinary System Drugs Breakdown Data by Application (2016-2027) 5.1 Global Urinary System Drugs Historic Market Size by Application (2016-2021) 5.2 Urinary System Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Urinary System Drugs Market Size (2016-2027) 6.2 Key Urinary System Drugs Players Market Share in North America (2020-2021) 6.3 North America Urinary System Drugs Market Size by Country 6.3.1 North America Urinary System Drugs Market Size by Country (2016-2021) 6.3.2 North America Urinary System Drugs Market Size Forecast by Country (2022-2027) 6.4 U.S. Market Size Analysis 6.4.1 U.S. Urinary System Drugs Market Size (2016-2027) 6.4.2 U.S. Urinary System Drugs Market Size by Type (2016-2027) 6.4.3 U.S. Urinary System Drugs Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis 6.5.1 Canada Urinary System Drugs Market Size (2016-2027) 6.5.2 Canada Urinary System Drugs Market Size by Type (2016-2027) 6.5.3 Canada Urinary System Drugs Market Size by Application (2016-2027) 7 Europe 7.1 Europe Urinary System Drugs Market Size (2016-2027) 7.2 Key Urinary System Drugs Players Market Share in Europe (2020-2021) 7.3 Europe Urinary System Drugs Market Size by Country 7.3.1 Europe Urinary System Drugs Market Size by Country (2016-2021) 7.3.2 Europe Urinary System Drugs Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis 7.4.1 Germany Urinary System Drugs Market Size (2016-2027) 7.4.2 Germany Urinary System Drugs Market Size by Type (2016-2027) 7.4.3 Germany Urinary System Drugs Market Size by Application (2016-2027) 7.5 France Market Size Analysis 7.5.1 France Urinary System Drugs Market Size (2016-2027) 7.5.2 France Urinary System Drugs Market Size by Type (2016-2027) 7.5.3 France Urinary System Drugs Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis 7.6.1 U.K. Urinary System Drugs Market Size (2016-2027) 7.6.2 U.K. Urinary System Drugs Market Size by Type (2016-2027) 7.6.3 U.K. Urinary System Drugs Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis 7.7.1 Italy Urinary System Drugs Market Size (2016-2027) 7.7.2 Italy Urinary System Drugs Market Size by Type (2016-2027) 7.7.3 Italy Urinary System Drugs Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis 7.8.1 Russia Urinary System Drugs Market Size (2016-2027) 7.8.2 Russia Urinary System Drugs Market Size by Type (2016-2027) 7.8.3 Russia Urinary System Drugs Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Urinary System Drugs Market Size (2016-2027) 8.2 Key Urinary System Drugs Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Urinary System Drugs Market Size by Region 8.3.1 Asia-Pacific Urinary System Drugs Market Size by Region (2016-2021) 8.3.2 Asia-Pacific Urinary System Drugs Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis 8.4.1 China Urinary System Drugs Market Size (2016-2027) 8.4.2 China Urinary System Drugs Market Size by Type (2016-2027) 8.4.3 China Urinary System Drugs Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis 8.5.1 Japan Urinary System Drugs Market Size (2016-2027) 8.5.2 Japan Urinary System Drugs Market Size by Type (2016-2027) 8.5.3 Japan Urinary System Drugs Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis 8.6.1 South Korea Urinary System Drugs Market Size (2016-2027) 8.6.2 South Korea Urinary System Drugs Market Size by Type (2016-2027) 8.6.3 South Korea Urinary System Drugs Market Size by Application (2016-2027) 8.7 India Market Size Analysis 8.7.1 India Urinary System Drugs Market Size (2016-2027) 8.7.2 India Urinary System Drugs Market Size by Type (2016-2027) 8.7.3 India Urinary System Drugs Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis 8.8.1 Australia Urinary System Drugs Market Size (2016-2027) 8.8.2 Australia Urinary System Drugs Market Size by Type (2016-2027) 8.8.3 Australia Urinary System Drugs Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis 8.9.1 Taiwan Urinary System Drugs Market Size (2016-2027) 8.9.2 Taiwan Urinary System Drugs Market Size by Type (2016-2027) 8.9.3 Taiwan Urinary System Drugs Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis 8.10.1 Indonesia Urinary System Drugs Market Size (2016-2027) 8.10.2 Indonesia Urinary System Drugs Market Size by Type (2016-2027) 8.10.3 Indonesia Urinary System Drugs Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis 8.11.1 Thailand Urinary System Drugs Market Size (2016-2027) 8.11.2 Thailand Urinary System Drugs Market Size by Type (2016-2027) 8.11.3 Thailand Urinary System Drugs Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis 8.12.1 Malaysia Urinary System Drugs Market Size (2016-2027) 8.12.2 Malaysia Urinary System Drugs Market Size by Type (2016-2027) 8.12.3 Malaysia Urinary System Drugs Market Size by Application (2016-2027) 8.13 Philippines Market Size Analysis 8.13.1 Philippines Urinary System Drugs Market Size (2016-2027) 8.13.2 Philippines Urinary System Drugs Market Size by Type (2016-2027) 8.13.3 Philippines Urinary System Drugs Market Size by Application (2016-2027) 8.14 Vietnam Market Size Analysis 8.14.1 Vietnam Urinary System Drugs Market Size (2016-2027) 8.14.2 Vietnam Urinary System Drugs Market Size by Type (2016-2027) 8.14.3 Vietnam Urinary System Drugs Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Urinary System Drugs Market Size (2016-2027) 9.2 Key Urinary System Drugs Players Market Share in Latin America (2020-2021) 9.3 Latin America Urinary System Drugs Market Size by Country 9.3.1 Latin America Urinary System Drugs Market Size by Country (2016-2021) 9.3.2 Latin America Urinary System Drugs Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis 9.4.1 Mexico Urinary System Drugs Market Size (2016-2027) 9.4.2 Mexico Urinary System Drugs Market Size by Type (2016-2027) 9.4.3 Mexico Urinary System Drugs Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis 9.5.1 Brazil Urinary System Drugs Market Size (2016-2027) 9.5.2 Brazil Urinary System Drugs Market Size by Type (2016-2027) 9.5.3 Brazil Urinary System Drugs Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis 9.6.1 Argentina Urinary System Drugs Market Size (2016-2027) 9.6.2 Argentina Urinary System Drugs Market Size by Type (2016-2027) 9.6.3 Argentina Urinary System Drugs Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Urinary System Drugs Market Size (2016-2027) 10.2 Key Urinary System Drugs Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Urinary System Drugs Market Size by Country 10.3.1 Middle East & Africa Urinary System Drugs Market Size by Country (2016-2021) 10.3.2 Middle East & Africa Urinary System Drugs Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis 10.4.1 Turkey Urinary System Drugs Market Size (2016-2027) 10.4.2 Turkey Urinary System Drugs Market Size by Type (2016-2027) 10.4.3 Turkey Urinary System Drugs Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis 10.5.1 Saudi Arabia Urinary System Drugs Market Size (2016-2027) 10.5.2 Saudi Arabia Urinary System Drugs Market Size by Type (2016-2027) 10.5.3 Saudi Arabia Urinary System Drugs Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis 10.6.1 UAE Urinary System Drugs Market Size (2016-2027) 10.6.2 UAE Urinary System Drugs Market Size by Type (2016-2027) 10.6.3 UAE Urinary System Drugs Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Details 11.1.2 Johnson & Johnson Business Overview and Its Total Revenue 11.1.3 Johnson & Johnson Urinary System Drugs Introduction 11.1.4 Johnson & Johnson Revenue in Urinary System Drugs Business (2016-2021) 11.1.5 Johnson & Johnson Recent Development 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview and Its Total Revenue 11.2.3 Bayer Urinary System Drugs Introduction 11.2.4 Bayer Revenue in Urinary System Drugs Business (2016-2021) 11.2.5 Bayer Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview and Its Total Revenue 11.3.3 Pfizer Urinary System Drugs Introduction 11.3.4 Pfizer Revenue in Urinary System Drugs Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 GSK 11.4.1 GSK Company Details 11.4.2 GSK Business Overview and Its Total Revenue 11.4.3 GSK Urinary System Drugs Introduction 11.4.4 GSK Revenue in Urinary System Drugs Business (2016-2021) 11.4.5 GSK Recent Development 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Details 11.5.2 Boehringer Ingelheim Business Overview and Its Total Revenue 11.5.3 Boehringer Ingelheim Urinary System Drugs Introduction 11.5.4 Boehringer Ingelheim Revenue in Urinary System Drugs Business (2016-2021) 11.5.5 Boehringer Ingelheim Recent Development 11.6 Roche 11.6.1 Roche Company Details 11.6.2 Roche Business Overview and Its Total Revenue 11.6.3 Roche Urinary System Drugs Introduction 11.6.4 Roche Revenue in Urinary System Drugs Business (2016-2021) 11.6.5 Roche Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview and Its Total Revenue 11.7.3 Novartis Urinary System Drugs Introduction 11.7.4 Novartis Revenue in Urinary System Drugs Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 AstraZeneca Business Overview and Its Total Revenue 11.8.3 AstraZeneca Urinary System Drugs Introduction 11.8.4 AstraZeneca Revenue in Urinary System Drugs Business (2016-2021) 11.8.5 AstraZeneca Recent Development 11.9 Dr. Reddy’s Laboratories 11.9.1 Dr. Reddy’s Laboratories Company Details 11.9.2 Dr. Reddy’s Laboratories Business Overview and Its Total Revenue 11.9.3 Dr. Reddy’s Laboratories Urinary System Drugs Introduction 11.9.4 Dr. Reddy’s Laboratories Revenue in Urinary System Drugs Business (2016-2021) 11.9.5 Dr. Reddy’s Laboratories Recent Development 11.10 Mylan 11.10.1 Mylan Company Details 11.10.2 Mylan Business Overview and Its Total Revenue 11.10.3 Mylan Urinary System Drugs Introduction 11.10.4 Mylan Revenue in Urinary System Drugs Business (2016-2021) 11.10.5 Mylan Recent Development 11.11 Sun Pharma 11.11.1 Sun Pharma Company Details 11.11.2 Sun Pharma Business Overview and Its Total Revenue 11.11.3 Sun Pharma Urinary System Drugs Introduction 11.11.4 Sun Pharma Revenue in Urinary System Drugs Business (2016-2021) 11.11.5 Sun Pharma Recent Development 11.12 Cipla 11.12.1 Cipla Company Details 11.12.2 Cipla Business Overview and Its Total Revenue 11.12.3 Cipla Urinary System Drugs Introduction 11.12.4 Cipla Revenue in Urinary System Drugs Business (2016-2021) 11.12.5 Cipla Recent Development 11.13 Merck 11.13.1 Merck Company Details 11.13.2 Merck Business Overview and Its Total Revenue 11.13.3 Merck Urinary System Drugs Introduction 11.13.4 Merck Revenue in Urinary System Drugs Business (2016-2021) 11.13.5 Merck Recent Development 11.14 Cubist Pharmaceuticals 11.14.1 Cubist Pharmaceuticals Company Details 11.14.2 Cubist Pharmaceuticals Business Overview and Its Total Revenue 11.14.3 Cubist Pharmaceuticals Urinary System Drugs Introduction 11.14.4 Cubist Pharmaceuticals Revenue in Urinary System Drugs Business (2016-2021) 11.14.5 Cubist Pharmaceuticals Recent Development 11.15 Abbott Laboratories 11.15.1 Abbott Laboratories Company Details 11.15.2 Abbott Laboratories Business Overview and Its Total Revenue 11.15.3 Abbott Laboratories Urinary System Drugs Introduction 11.15.4 Abbott Laboratories Revenue in Urinary System Drugs Business (2016-2021) 11.15.5 Abbott Laboratories Recent Development 11.16 Eli Lilly 11.16.1 Eli Lilly Company Details 11.16.2 Eli Lilly Business Overview and Its Total Revenue 11.16.3 Eli Lilly Urinary System Drugs Introduction 11.16.4 Eli Lilly Revenue in Urinary System Drugs Business (2016-2021) 11.16.5 Eli Lilly Recent Development 11.17 Melinta Therapeutics 11.17.1 Melinta Therapeutics Company Details 11.17.2 Melinta Therapeutics Business Overview and Its Total Revenue 11.17.3 Melinta Therapeutics Urinary System Drugs Introduction 11.17.4 Melinta Therapeutics Revenue in Urinary System Drugs Business (2016-2021) 11.17.5 Melinta Therapeutics Recent Development 11.18 Sanofi 11.18.1 Sanofi Company Details 11.18.2 Sanofi Business Overview and Its Total Revenue 11.18.3 Sanofi Urinary System Drugs Introduction 11.18.4 Sanofi Revenue in Urinary System Drugs Business (2016-2021) 11.18.5 Sanofi Recent Development 11.19 Daiichi Sankyo 11.19.1 Daiichi Sankyo Company Details 11.19.2 Daiichi Sankyo Business Overview and Its Total Revenue 11.19.3 Daiichi Sankyo Urinary System Drugs Introduction 11.19.4 Daiichi Sankyo Revenue in Urinary System Drugs Business (2016-2021) 11.19.5 Daiichi Sankyo Recent Development 11.20 Lupin 11.20.1 Lupin Company Details 11.20.2 Lupin Business Overview and Its Total Revenue 11.20.3 Lupin Urinary System Drugs Introduction 11.20.4 Lupin Revenue in Urinary System Drugs Business (2016-2021) 11.20.5 Lupin Recent Development 11.21 Apogepha 11.21.1 Apogepha Company Details 11.21.2 Apogepha Business Overview and Its Total Revenue 11.21.3 Apogepha Urinary System Drugs Introduction 11.21.4 Apogepha Revenue in Urinary System Drugs Business (2016-2021) 11.21.5 Apogepha Recent Development 11.22 Astellas Pharma 11.22.1 Astellas Pharma Company Details 11.22.2 Astellas Pharma Business Overview and Its Total Revenue 11.22.3 Astellas Pharma Urinary System Drugs Introduction 11.22.4 Astellas Pharma Revenue in Urinary System Drugs Business (2016-2021) 11.22.5 Astellas Pharma Recent Development 11.23 Dr. Dunner 11.23.1 Dr. Dunner Company Details 11.23.2 Dr. Dunner Business Overview and Its Total Revenue 11.23.3 Dr. Dunner Urinary System Drugs Introduction 11.23.4 Dr. Dunner Revenue in Urinary System Drugs Business (2016-2021) 11.23.5 Dr. Dunner Recent Development 11.24 Kowa 11.24.1 Kowa Company Details 11.24.2 Kowa Business Overview and Its Total Revenue 11.24.3 Kowa Urinary System Drugs Introduction 11.24.4 Kowa Revenue in Urinary System Drugs Business (2016-2021) 11.24.5 Kowa Recent Development 11.25 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical 11.25.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details 11.25.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Business Overview and Its Total Revenue 11.25.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Urinary System Drugs Introduction 11.25.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Revenue in Urinary System Drugs Business (2016-2021) 11.25.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Development 11.26 Tianjin Tongrentang Group 11.26.1 Tianjin Tongrentang Group Company Details 11.26.2 Tianjin Tongrentang Group Business Overview and Its Total Revenue 11.26.3 Tianjin Tongrentang Group Urinary System Drugs Introduction 11.26.4 Tianjin Tongrentang Group Revenue in Urinary System Drugs Business (2016-2021) 11.26.5 Tianjin Tongrentang Group Recent Development 11.27 Jiangsu Hengrui Pharmaceutical 11.27.1 Jiangsu Hengrui Pharmaceutical Company Details 11.27.2 Jiangsu Hengrui Pharmaceutical Business Overview and Its Total Revenue 11.27.3 Jiangsu Hengrui Pharmaceutical Urinary System Drugs Introduction 11.27.4 Jiangsu Hengrui Pharmaceutical Revenue in Urinary System Drugs Business (2016-2021) 11.27.5 Jiangsu Hengrui Pharmaceutical Recent Development 11.28 Hunan Qianjin Xiang River Pharmaceutical 11.28.1 Hunan Qianjin Xiang River Pharmaceutical Company Details 11.28.2 Hunan Qianjin Xiang River Pharmaceutical Business Overview and Its Total Revenue 11.28.3 Hunan Qianjin Xiang River Pharmaceutical Urinary System Drugs Introduction 11.28.4 Hunan Qianjin Xiang River Pharmaceutical Revenue in Urinary System Drugs Business (2016-2021) 11.28.5 Hunan Qianjin Xiang River Pharmaceutical Recent Development 11.29 Kunming Jida Pharmaceutical 11.29.1 Kunming Jida Pharmaceutical Company Details 11.29.2 Kunming Jida Pharmaceutical Business Overview and Its Total Revenue 11.29.3 Kunming Jida Pharmaceutical Urinary System Drugs Introduction 11.29.4 Kunming Jida Pharmaceutical Revenue in Urinary System Drugs Business (2016-2021) 11.29.5 Kunming Jida Pharmaceutical Recent Development 11.30 Jiangsu Lianhuan Pharmaceutical 11.30.1 Jiangsu Lianhuan Pharmaceutical Company Details 11.30.2 Jiangsu Lianhuan Pharmaceutical Business Overview and Its Total Revenue 11.30.3 Jiangsu Lianhuan Pharmaceutical Urinary System Drugs Introduction 11.30.4 Jiangsu Lianhuan Pharmaceutical Revenue in Urinary System Drugs Business (2016-2021) 11.30.5 Jiangsu Lianhuan Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Urinary System Drugs Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027 Table 2. Key Players of Injection Table 3. Key Players of Tablets Table 4. Key Players of Capsule Table 5. Key Players of Suppository Table 6. Key Players of Granules Table 7. Key Players of Powder Table 8. Key Players of Pills Table 9. Key Players of Cream Table 10. Key Players of Others Table 11. Global Urinary System Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Urinary System Drugs Market Size by Region (US$ Million): 2016 VS 2021 VS 2027 Table 13. Global Urinary System Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 14. Global Urinary System Drugs Market Share by Regions (2016-2021) Table 15. Global Urinary System Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 16. Global Urinary System Drugs Market Share by Regions (2022-2027) Table 17. Urinary System Drugs Market Trends Table 18. Urinary System Drugs Market Drivers Table 19. Urinary System Drugs Market Challenges Table 20. Urinary System Drugs Market Restraints Table 21. Ranking of Global Top Urinary System Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 22. Global Urinary System Drugs Revenue by Players (2016-2021) & (US$ Million) Table 23. Global Urinary System Drugs Market Share by Players (2016-2021) Table 24. Global Top Urinary System Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary System Drugs as of 2020) Table 25. Global 5 Largest Players Market Share by Urinary System Drugs Revenue (CR5 and HHI) (2016-2021) Table 26. Key Players Headquarters and Area Served Table 27. Key Players Urinary System Drugs Product Solution and Service Table 28. Date of Enter into Urinary System Drugs Market Table 29. Mergers & Acquisitions, Expansion Plans Table 30. Global Urinary System Drugs Market Size by Type (2016-2021) & (US$ Million) Table 31. Global Urinary System Drugs Revenue Market Share by Type (2016-2021) Table 32. Global Urinary System Drugs Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 33. Global Urinary System Drugs Revenue Market Share by Type (2022-2027) Table 34. Global Urinary System Drugs Market Size by Application (2016-2021) & (US$ Million) Table 35. Global Urinary System Drugs Revenue Market Share by Application (2016-2021) Table 36. Global Urinary System Drugs Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 37. Global Urinary System Drugs Revenue Market Share by Application (2022-2027) Table 38. Key Players Urinary System Drugs Revenue in North America (2020-2021) (US$ Million) Table 39. North America Urinary System Drugs Market Size by Countries (2016-2021) & (US$ Million) Table 40. North America Urinary System Drugs Market Size Share by Countries (2016-2021) Table 41. North America Urinary System Drugs Market Size by Countries (2022-2027) & (US$ Million) Table 42. North America Urinary System Drugs Market Size Share by Countries (2022-2027) Table 43. Urinary System Drugs Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021) Table 44. Urinary System Drugs Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027) Table 45. Urinary System Drugs Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021) Table 46. Urinary System Drugs Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027) Table 47. Urinary System Drugs Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021) Table 48. Urinary System Drugs Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027) Table 49. Urinary System Drugs Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021) Table 50. Urinary System Drugs Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027) Table 51. Key Players Urinary System Drugs Revenue in Europe (2020-2021) (US$ Million) Table 52. Europe Urinary System Drugs Market Size by Countries (2016-2021) & (US$ Million) Table 53. Europe Urinary System Drugs Market Size Share by Countries (2016-2021) Table 54. Europe Urinary System Drugs Market Size by Countries (2022-2027) & (US$ Million) Table 55. Europe Urinary System Drugs Market Size Share by Countries (2022-2027) Table 56. Urinary System Drugs Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021) Table 57. Urinary System Drugs Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027) Table 58. Urinary System Drugs Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021) Table 59. Urinary System Drugs Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027) Table 60. Urinary System Drugs Market Size (US$ Million) in France, Breakdown by Type (2016-2021) Table 61. Urinary System Drugs Market Size (US$ Million) in France, Breakdown by Type (2022-2027) Table 62. Urinary System Drugs Market Size (US$ Million) in France, Breakdown by Application (2016-2021) Table 63. Urinary System Drugs Market Size (US$ Million) in France, Breakdown by Application (2022-2027) Table 64. Urinary System Drugs Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021) Table 65. Urinary System Drugs Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027) Table 66. Urinary System Drugs Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021) Table 67. Urinary System Drugs Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027) Table 68. Urinary System Drugs Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021) Table 69. Urinary System Drugs Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027) Table 70. Urinary System Drugs Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021) Table 71. Urinary System Drugs Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027) Table 72. Urinary System Drugs Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021) Table 73. Urinary System Drugs Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027) Table 74. Urinary System Drugs Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021) Table 75. Urinary System Drugs Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027) Table 76. Key Players Urinary System Drugs Revenue in Asia-Pacific (2020-2021) (US$ Million) Table 77. Asia-Pacific Urinary System Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 78. Asia-Pacific Urinary System Drugs Market Size by Regions (2022-2027) & (US$ Million) Table 79. Urinary System Drugs Market Size (US$ Million) in China, Breakdown by Type (2016-2021) Table 80. Urinary System Drugs Market Size (US$ Million) in China, Breakdown by Type (2022-2027) Table 81. Urinary System Drugs Market Size (US$ Million) in China, Breakdown by Application (2016-2021) Table 82. Urinary System Drugs Market Size (US$ Million) in China, Breakdown by Application (2022-2027) Table 83. Urinary System Drugs Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021) Table 84. Urinary System Drugs Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027) Table 85. Urinary System Drugs Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021) Table 86. Urinary System Drugs Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027) Table 87. Urinary System Drugs Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021) Table 88. Urinary System Drugs Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027) Table 89. Urinary System Drugs Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021) Table 90. Urinary System Drugs Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027) Table 91. Urinary System Drugs Market Size (US$ Million) in India, Breakdown by Type (2016-2021) Table 92. Urinary System Drugs Market Size (US$ Million) in India, Breakdown by Type (2022-2027) Table 93. Urinary System Drugs Market Size (US$ Million) in India, Breakdown by Application (2016-2021) Table 94. Urinary System Drugs Market Size (US$ Million) in India, Breakdown by Application (2022-2027) Table 95. Urinary System Drugs Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021) Table 96. Urinary System Drugs Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027) Table 97. Urinary System Drugs Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021) Table 98. Urinary System Drugs Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027) Table 99. Urinary System Drugs Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021) Table 100. Urinary System Drugs Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027) Table 101. Urinary System Drugs Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021) Table 102. Urinary System Drugs Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027) Table 103. Urinary System Drugs Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021) Table 104. Urinary System Drugs Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027) Table 105. Urinary System Drugs Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021) Table 106. Urinary System Drugs Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027) Table 107. Key Players Urinary System Drugs Revenue in Latin America (2020-2021) (US$ Million) Table 108. Latin America Urinary System Drugs Market Size by Countries (2016-2021) & (US$ Million) Table 109. Latin America Urinary System Drugs Market Size by Countries (2022-2027) & (US$ Million) Table 110. Urinary System Drugs Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021) Table 111. Urinary System Drugs Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027) Table 112. Urinary System Drugs Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021) Table 113. Urinary System Drugs Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027) Table 114. Urinary System Drugs Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021) Table 115. Urinary System Drugs Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027) Table 116. Urinary System Drugs Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021) Table 117. Urinary System Drugs Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027) Table 118. Urinary System Drugs Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021) Table 119. Urinary System Drugs Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027) Table 120. Urinary System Drugs Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021) Table 121. Urinary System Drugs Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027) Table 122. Key Players Urinary System Drugs Revenue in Middle East & Africa (2020-2021) (US$ Million) Table 123. Middle East & Africa Urinary System Drugs Market Size by Countries (2016-2021) & (US$ Million) Table 124. Middle East & Africa Urinary System Drugs Market Size by Countries (2022-2027) & (US$ Million) Table 125. Urinary System Drugs Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021) Table 126. Urinary System Drugs Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027) Table 127. Urinary System Drugs Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021) Table 128. Urinary System Drugs Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027) Table 129. Urinary System Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021) Table 130. Urinary System Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027) Table 131. Urinary System Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021) Table 132. Urinary System Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027) Table 133. Urinary System Drugs Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021) Table 134. Urinary System Drugs Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027) Table 135. Urinary System Drugs Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021) Table 136. Urinary System Drugs Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027) Table 137. Johnson & Johnson Company Details Table 138. Johnson & Johnson Business Overview Table 139. Johnson & Johnson Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 140. Johnson & Johnson Urinary System Drugs Urinary System Drugs Product Table 141. Johnson & Johnson Recent Development Table 142. Bayer Company Details Table 143. Bayer Business Overview Table 144. Bayer Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 145. Bayer Urinary System Drugs Product Table 146. Bayer Recent Development Table 147. Pfizer Company Details Table 148. Pfizer Business Overview Table 149. Pfizer Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 150. Pfizer Urinary System Drugs Product Table 151. Pfizer Recent Development Table 152. GSK Company Details Table 153. GSK Business Overview Table 154. GSK Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 155. GSK Urinary System Drugs Product Table 156. GSK Recent Development Table 157. Boehringer Ingelheim Company Details Table 158. Boehringer Ingelheim Business Overview Table 159. Boehringer Ingelheim Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 160. Boehringer Ingelheim Urinary System Drugs Product Table 161. Boehringer Ingelheim Recent Development Table 162. Roche Company Details Table 163. Roche Business Overview Table 164. Roche Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 165. Roche Urinary System Drugs Product Table 166. Roche Recent Development Table 167. Novartis Company Details Table 168. Novartis Business Overview Table 169. Novartis Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 170. Novartis Urinary System Drugs Product Table 171. Novartis Recent Development Table 172. AstraZeneca Company Details Table 173. AstraZeneca Business Overview Table 174. AstraZeneca Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 175. AstraZeneca Urinary System Drugs Product Table 176. AstraZeneca Recent Development Table 177. Dr. Reddy’s Laboratories Company Details Table 178. Dr. Reddy’s Laboratories Business Overview Table 179. Dr. Reddy’s Laboratories Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 180. Dr. Reddy’s Laboratories Urinary System Drugs Product Table 181. Dr. Reddy’s Laboratories Recent Development Table 182. Mylan Company Details Table 183. Mylan Business Overview Table 184. Mylan Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 185. Mylan Urinary System Drugs Product Table 186. Mylan Recent Development Table 187. Sun Pharma Company Details Table 188. Sun Pharma Business Overview Table 189. Sun Pharma Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 190. Sun Pharma Urinary System Drugs Product Table 191. Sun Pharma Recent Development Table 192. Cipla Company Details Table 193. Cipla Business Overview Table 194. Cipla Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 195. Cipla Urinary System Drugs Product Table 196. Cipla Recent Development Table 197. Merck Company Details Table 198. Merck Business Overview Table 199. Merck Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 200. Merck Urinary System Drugs Product Table 201. Merck Recent Development Table 202. Cubist Pharmaceuticals Company Details Table 203. Cubist Pharmaceuticals Business Overview Table 204. Cubist Pharmaceuticals Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 205. Cubist Pharmaceuticals Urinary System Drugs Product Table 206. Cubist Pharmaceuticals Recent Development Table 207. Abbott Laboratories Company Details Table 208. Abbott Laboratories Business Overview Table 209. Abbott Laboratories Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 210. Abbott Laboratories Urinary System Drugs Product Table 211. Abbott Laboratories Recent Development Table 212. Eli Lilly Company Details Table 213. Eli Lilly Business Overview Table 214. Eli Lilly Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 215. Eli Lilly Urinary System Drugs Product Table 216. Eli Lilly Recent Development Table 217. Melinta Therapeutics Company Details Table 218. Melinta Therapeutics Business Overview Table 219. Melinta Therapeutics Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 220. Melinta Therapeutics Urinary System Drugs Product Table 221. Melinta Therapeutics Recent Development Table 222. Sanofi Company Details Table 223. Sanofi Business Overview Table 224. Sanofi Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 225. Sanofi Urinary System Drugs Product Table 226. Sanofi Recent Development Table 227. Daiichi Sankyo Company Details Table 228. Daiichi Sankyo Business Overview Table 229. Daiichi Sankyo Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 230. Daiichi Sankyo Urinary System Drugs Product Table 231. Daiichi Sankyo Recent Development Table 232. Lupin Company Details Table 233. Lupin Business Overview Table 234. Lupin Revenue in Urinary System Drugs Business (2016-2021) & (US$ Million) Table 235. Lupin Urinary System Drugs Product Table 236. Lupin Recent Development Table 237. Apogepha Company Details Table 238. Astellas Pharma Company Details Table 239. Dr. Dunner Company Details Table 240. Kowa Company Details Table 241. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Details Table 242. Tianjin Tongrentang Group Company Details Table 243. Jiangsu Hengrui Pharmaceutical Company Details Table 244. Hunan Qianjin Xiang River Pharmaceutical Company Details Table 245. Kunming Jida Pharmaceutical Company Details Table 246. Jiangsu Lianhuan Pharmaceutical Company Details Table 247. Research Programs/Design for This Report Table 248. Key Data Information from Secondary Sources Table 249. Key Data Information from Primary Sources List of Figures Figure 1. Global Urinary System Drugs Market Share by Type: 2020 & 2027 Figure 2. Injection Features Figure 3. Tablets Features Figure 4. Capsule Features Figure 5. Suppository Features Figure 6. Granules Features Figure 7. Powder Features Figure 8. Pills Features Figure 9. Cream Features Figure 10. Others Features Figure 11. Global Urinary System Drugs Market Share by Application: 2020 & 2027 Figure 12. Kidney Disease Medication Case Studies Figure 13. Medication For Prostate Disease Case Studies Figure 14. Male Dysfunction Case Studies Figure 15. Lithotripsy Drug Case Studies Figure 16. Others Case Studies Figure 17. Urinary System Drugs Report Years Considered Figure 18. Global Urinary System Drugs Market Share by Regions: 2016 VS 2021 VS 2027 Figure 19. Global Urinary System Drugs Market Size YoY Growth 2016-2027 (US$ Million) Figure 20. Global Urinary System Drugs Market Share by Regions (2022-2027) Figure 21. Global Urinary System Drugs Market Share by Players in 2020 Figure 22. Global Top Urinary System Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary System Drugs as of 2020) Figure 23. The Top 10 and 5 Players Market Share by Urinary System Drugs Revenue in 2020 Figure 24. North America Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. U.S. Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Germany Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. China Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Japan Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. South Korea Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. India Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Australia Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Taiwan Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Indonesia Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Thailand Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Malaysia Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Philippines Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Vietnam Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Mexico Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Brazil Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Argentina Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Turkey Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Saudi Arabia Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. UAE Urinary System Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Johnson & Johnson Bayer Pfizer GSK Boehringer Ingelheim Roche Novartis AstraZeneca Dr. Reddy’s Laboratories Mylan Sun Pharma Cipla Merck Cubist Pharmaceuticals Abbott Laboratories Eli Lilly Melinta Therapeutics Sanofi Daiichi Sankyo Lupin Apogepha Astellas Pharma Dr. Dunner Kowa Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Tianjin Tongrentang Group Jiangsu Hengrui Pharmaceutical Hunan Qianjin Xiang River Pharmaceutical Kunming Jida Pharmaceutical Jiangsu Lianhuan Pharmaceutical